AlphAIAlphAI — Financial news for AI agents
SEC EDGARAUG 32 min read$HUN

Huntsman Peter R purchased $981K of HUN

Huntsman Peter R (Chairman, President & CEO) purchased 100,000 shares of Huntsman CORP (HUN) at $9.81 ($0.98M total) on 2026-08-03.

Original reporting
SEC EDGAR · Huntsman Peter R
Published Aug 3, 2026, 4:00 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 6, 2026, 6:15 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefInsider activity
Primary signal
$HUN
Bullish
medium confidence
Mentioned
$HUN
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$HUNBullishLow
01

Why it matters

The newest fact is the CEO’s open-market purchase of 100,000 shares at $9.81/share on 2026-08-03, with post-transaction holdings of 7,256,341 shares.

02

Market read

This provides a fresh insider-buy datapoint for HUN, but it does not introduce operational or financial changes.

03

What to watch

The disclosure lacks context on prior trading, motivations, and whether the purchase is part of a broader compensation or liquidity strategy.

Relevance 6/10Novelty 4/10Timing: filed 2026-08-03, after-hours/market close timing per accession timestamp

Background

The article is a SEC Form 4 insider transaction disclosure for Huntsman Corp.

Company-level read

Ticker impact

$HUNBullishMedium confidence
Context

Huntsman CEO Peter R bought 100,000 shares of HUN in an open-market Form 4 on 2026-08-03 at $9.81/share.

Expected impact

Likely limited near-term impact; any effect is sentiment-driven and typically fades unless followed by additional disclosures.

Evidence & confidence

The filing is a primary-source insider transaction with clear size and price, but it does not include new earnings, guidance, contracts, or regulatory developments.

Market effects

Sector

No direct sector read-through; this is company-specific insider activity.

Regional

None indicated.

Global

None indicated.

Counterpoint

What could challenge this read

Insider purchases can be routine or planned; the article notes no 10b5-1 plan, but it still does not prove a new bullish thesis.

Key entities

  • issuer
    Huntsman Corp

    Subject of the Form 4 insider transaction disclosure.

  • insider
    Huntsman Peter R

    Chairman, President and CEO who reported the open-market purchase.

Read at source← All news

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

HUN insider trading history →

Related articles

SEP 14
$OLNHighAI 9/10

Olin, Huntsman Merger of Equals Clears U.S. Antitrust Hurdle

Olin (OLN) and Huntsman (HUN) cleared a U.S. antitrust hurdle for their all-stock merger, expected to create a $12.5B chemicals company with $400M in cost synergies. The deal, targeting 1H 2027 completion, still needs regulatory approvals. OLN shares fell 32.2% and HUN dropped 8.6% over the past year.

finance.yahoo.com3 min
SEP 11
$OLNHighAI 9/10

Olin and Huntsman merger clears antitrust waiting period

Olin (OLN) and Huntsman (HUN) cleared the U.S. antitrust waiting period for their proposed merger. The milestone satisfies one closing condition, but additional regulatory approvals and customary closing conditions are still required. Olin is a chemical manufacturer and ammunition producer, while Huntsman is a diversified chemicals company with $6B in 2025 revenue.

grafa.com1 min
SEP 11
$OLNMedAI 9/10

Olin Corporation; Huntsman Corporation: OLIN and HUNTSMAN Announce Expiration of Hart-Scott-Rodino Waiting Period for Proposed Merger

Olin (OLN) and Huntsman (HUN) announced the expiration of the HSR Act waiting period for their proposed merger, satisfying a key closing condition. Shareholders approved the transaction, but regulatory approvals are still required. Olin is a chemical and ammunition manufacturer, while Huntsman is a diversified chemical producer with 2025 revenues of $6 billion.

finanznachrichten.de2 min